Clinical Trial Update: Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate the efficacy and safety of LivPhcD Capsules in subjects with non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• LivPhcD Capsules

Snippet

Sponsor: TCM Biotech International Corp. | Conditions: NAFLD | NA | Status: RECRUITING